selected publications academic article The anti-COVID-19 drug Favipiravir: Degradation, Method development, Validation, NMR/LC–MS characterization, and In-vitro safety evaluation. Chemical Papers. 76:6415-6426. 2022 Greenness assessment of micellar spectrofluorometric approach for determination of Elagolix: application to dosage form, content uniformity and human plasma. Heliyon. 7:e08521. 2021 Insights into flibanserin oxidative stress degradation pathway: in silico – in vitro toxicity assessment of its degradates. New Journal of Chemistry. 45:2620-2630. 2021 فاعلية برنامج إثرائى باستخدام المحطات العلمية فى تنمية الدافعية لتعلم العلوم لدى تلاميذ المرحلة الاعدادية. المجلة المصرية للتربية العلمية. 24:36-60. 2021 Determination of flibanserin in the presence of confirmed degradation products by a third derivative emission spectrofluorometric method: Application to pharmaceutical formulation. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 225:117491. 2020 Development and Greenness Evaluation of Spectrofluorometric Methods for Flibanserin Determination in Dosage Form and Human Urine Samples. Molecules. 25:4932. 2020 Identification, isolation, structural characterization, in silico toxicity prediction and in vitro cytotoxicity assay of simeprevir acidic and oxidative degradation products. RSC Advances. 10:42816-42826. 2020 Univariate and Chemometrics-Assisted Spectrophotometric Methods for Determination of Flibanserin in a Recently Released Dosage Form. Journal of Applied Spectroscopy. 87:976-985. 2020